Y-Intercept (HK)’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Buy
+12,318
New +$316K 0.01% 1410
2026
Q1
Sell
-11,346
Closed -$161K 1505
2025
Q4
$161K Buy
11,346
+1,733
+18% +$32.8K ﹤0.01% 1451
2025
Q3
$238K Sell
9,613
-61,546
-86% -$1.37M 0.01% 1438
2025
Q2
$1.61M Buy
71,159
+43,746
+160% +$1.04M 0.04% 699
2025
Q1
$831K Sell
27,413
-1,632
-6% -$62.2K 0.06% 486
2024
Q4
$1.15M Sell
29,045
-7,560
-21% -$341K 0.08% 369
2024
Q3
$2.32M Buy
36,605
+10,572
+41% +$763K 0.14% 171
2024
Q2
$1.76M Buy
26,033
+22,682
+677% +$1.58M 0.1% 281
2024
Q1
$265K Buy
+3,351
New +$274K 0.02% 1012

Other funds holding ACHC

Y-Intercept (HK)'s ACHC Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 12,318 shares worth $364K. The stake represents 0.01% of the portfolio and ranks #1410 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ACHC as recently as Q4 2025.

Y-Intercept (HK) first reported a position in ACHC in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.32M in Q3 2024. 38 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Y-Intercept (HK) held 12,318 shares of Acadia Healthcare worth $364K as of Q2 2026.
  • Acadia Healthcare was a new Y-Intercept (HK) position in Q2 2026.
  • Acadia Healthcare made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1410 holding.
  • Y-Intercept (HK) first reported a position in Acadia Healthcare in Q1 2024 and has held it in 9 quarters since.
  • Y-Intercept (HK)'s Acadia Healthcare position peaked at $2.32M in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.